Myriad Genetics opened lower at $5.69, compared with its previous close of $5.72. In the last trading session, the stock traded between $5.47 and $5.86. It showed a sideways intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Myriad Genetics is now worth
$ 18.05
Resulting in a loss of
$ 81.95 (81.95%)
Invest with $1
Note: Past profits do not guarantee future returns.
Stephens & Co. raised Myriad Genetics' price target to $6 from $3. Analyst Mason Carrico maintained an Equal-Weight rating on the stock. The price target increase represents a 100% upward revision.
Today
6Nov
TD Cowen raises Myriad Genetics price target to $6.75, keeps Hold
TD Cowen raised the price target for Myriad Genetics from $4.50 to $6.75. Analyst Kyle Boucher maintained a Hold rating on the stock. The revision reflects an increase of $2.25 in the projected share value.
Leerink Partners raised Myriad Genetics' price target from $5 to $8. The firm maintained a Market Perform rating on the stock. Analyst Puneet Souda issued the revised rating and target.
7 days ago
5Nov
Myriad Genetics suspends testing after unauthorized network access
Myriad Genetics detected unauthorized IT network access on November 2. Testing operations and order management systems temporarily suspended. Forensic investigation underway to assess potential patient record exposure.
7 days ago
5Nov
Myriad Genetics Q3FY26 Results: Revenue down 1% YoY to $202.7M
Total revenue reached $202.7 million, down 1% YoY but up 6% QoQ. Announced sale of prenatal health business to LabCorp for $210 million cash. Gross margin improved to 67.9%, up 130 bps sequentially. Full-year 2026 revenue guidance raised to $780–$790 million. Cancer Care Continuum revenue grew 1% YoY to $124 million on 4% volume rise.
8 days ago
16Oct
Myriad Genetics to report Q3FY26 results on November 4, 2026
Myriad Genetics will release Q3 2026 financial results on November 4, 2026. Conference call scheduled for 4:30 pm ET on the same day. Live webcast available via Investor Relations website.
